Earnings call transcript: Rigetti Computing Q2 2025 sees revenue drop, stock dips

Rigetti Computing Inc. (RGTI) reported Q2 2025 financial results below expectations, with revenue of $1.8 million down significantly year-over-year and gross margins sharply reduced, leading to a 2.13% stock decline in after-hours trading. Despite these financial misses and a widened net loss, the company highlighted significant technological progress, launching the CPS-136Q, the industry's largest multi-chip quantum computer with 99.5% median two-qubit gate fidelity. Rigetti maintains a strong $571.6 million cash position and aims for a 100+ qubit system by year-end, targeting quantum advantage within four years via its scalable chiplet architecture, underscoring a long-term growth strategy amid market challenges.

Analysis

Rigetti Computing's Q2 2025 results present a stark contrast between deteriorating current financials and significant long-term technological progress. The company missed revenue forecasts, reporting $1.8 million against an expected $1.87 million, marking a 42% year-over-year decline. This downturn was attributed to the expiration and pending reauthorization of the National Quantum Initiative. Gross margins collapsed to 31% from 64% in the prior year, and the net loss widened substantially to $39.7 million, driven by higher operating expenses and non-cash warrant charges. This financial underperformance triggered a 2.13% after-hours stock decline. However, the operational narrative is fundamentally different. Rigetti successfully launched its CPS-136Q, the industry's largest multi-chip quantum computer, and achieved a key performance milestone with a 99.5% median two-qubit gate fidelity. This achievement validates its chiplet-based scaling strategy, which management believes is the most viable path to quantum advantage. With a robust cash position of $571.6 million and no debt following a recent equity offering, the company is well-funded to pursue its ambitious four-year roadmap to a 1,000+ qubit system, mitigating immediate financing risk. The investment thesis hinges on the company's ability to execute this technological roadmap ahead of competitors, as current financial metrics will likely remain weak and volatile, heavily dependent on government contract timing.

Key Decisions for Investors

• Given the significant technological milestones and a fully funded multi-year roadmap, long-term investors may consider the post-earnings weakness an opportunity, focusing on the upcoming 100+ qubit system demonstration as the next major catalyst.
• Investors should closely monitor the progress of the National Quantum Initiative (NQI) reauthorization in the U.S. Congress, as the company's revenue is highly dependent on government contracts and further delays could negatively impact future financial performance.
• Due to the stock's extreme volatility and its status as a pre-commercialization technology play, any position should be sized for high-risk profiles, with the understanding that valuation is driven by technological milestones rather than near-term profitability.